When proteins get stuck at solid: Unlocking the secrets to brain diseases
Nanoscale view of proteins opens window to treat neurodegenerative illness
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
New report sets out clear steps pharma cos to curb AMR risk in antibiotic production
The report also demonstrates how proactively adopting and scaling responsible manufacturing practices is a critical way for…
Shiva Pharmachem files DRHP for Rs 900 cr IPO
The IPO with a face value of Rs 2 each is entirely an offer for sale (OFS) of up to Rs 900 crore by Promoter and Promoter Group…
Marksans receives USFDA approval for Guaifenesin ER Tablets (OTC)
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways…
Top 20 global biopharma companies report 2.3 per cent market cap growth in Q2 2023: GlobalData
Market cap surged from $3.49 trillion during the first quarter (Q1) of 2023 to $3.56 trillion in Q2 2023
US FDA places partial clinical hold on Gilead’s studies on Magrolimab for AML treatment
The FDA action follows the previously announced discontinuation of the Phase 3 ENHANCE study of magrolimab in higher-risk…
US FDA approves ABRYSVO, Pfizer’s maternal RSV vaccine for infants
First and only US approval of a maternal vaccine to help protect infants at birth through six months of life from lower…
Avantor inaugurates expanded Singapore hub
Facility to serve AMEA’s biopharma industry
Biden administration to urge Americans get COVID-19 boosters
The official said that while the Centers for Disease Control and Prevention are reporting an increase in infections and hospital…
Industry backlash may reshape EU compulsory pharma licensing reform: GlobalData
Both Johnson & Johnson and Pfizer criticised the changes by referencing the positive role of patents in incentivising their…